SOFTWARE SUPPORT FOR PHARMACOVIGILANCE INFORMATION IN BELGIAN COMMUNITY PHARMACIES
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: VAN BROECK, Dorien (ASSOCIATION PHARMACEUTIQUE BELGE, CIP-CFI, Bruxelles, Belgium)
- Co-author(s): Dorien Van Broeck
Pharmacovigilance legislation has a significant impact on EU marketing authorisation holders. The information comes to healthcare providers in various forms and is disseminated through various channels: some products are black triangle (BT) medicines, some have additional risk minimisation activities (RMA) and for others, direct healthcare.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.